Capture

PRODUCTS

  • Compliance solutions for product development agility and audit readiness.

  • Selecting the right medium to optimally match your cell line and process can be challenging. Our Cellvento®CHO media portfolio provides you with process and cell line specific cell culture media and feeds – so that you can find the most suitable product for your application.

  • Allogeneic CAR-T Cells Vs Autologous

    Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. Clinical trials with autologous CAR-T cells have shown very promising results and led to the approval of numerous CAR-T cell therapies.

  • The CliniMACS Prodigy® represents the next generation in automated cell processing. This device offers advanced integrated solutions to streamline cell processing workflows – from cell separation through cell culture to formulation of the final product.

  • Industry leading pharmacovigilance solutions from clinical development through post-approval.

WHITE PAPERS AND CASE STUDIES

NEWS